nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorescein—ABCC1—Vemurafenib—skin cancer	0.339	0.403	CbGbCtD
Fluorescein—ABCC1—Dactinomycin—skin cancer	0.225	0.268	CbGbCtD
Fluorescein—CYP1A1—Dacarbazine—skin cancer	0.16	0.191	CbGbCtD
Fluorescein—ABCC1—Docetaxel—skin cancer	0.116	0.138	CbGbCtD
Fluorescein—Dysphasia—Temozolomide—skin cancer	0.00589	0.037	CcSEcCtD
Fluorescein—Feeling hot—Imiquimod—skin cancer	0.00273	0.0172	CcSEcCtD
Fluorescein—Neoplasm—Vemurafenib—skin cancer	0.00227	0.0143	CcSEcCtD
Fluorescein—Aphasia—Temozolomide—skin cancer	0.00198	0.0124	CcSEcCtD
Fluorescein—Pulmonary oedema—Imiquimod—skin cancer	0.00191	0.012	CcSEcCtD
Fluorescein—Extravasation—Bleomycin—skin cancer	0.00175	0.011	CcSEcCtD
Fluorescein—Dysgeusia—Vismodegib—skin cancer	0.00174	0.0109	CcSEcCtD
Fluorescein—Eczema—Imiquimod—skin cancer	0.00173	0.0109	CcSEcCtD
Fluorescein—Nasal congestion—Imiquimod—skin cancer	0.00171	0.0107	CcSEcCtD
Fluorescein—Extravasation—Dactinomycin—skin cancer	0.00163	0.0102	CcSEcCtD
Fluorescein—Cerebrovascular accident—Imiquimod—skin cancer	0.00159	0.00998	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.0015	0.00945	CcSEcCtD
Fluorescein—Nervous system disorder—Vismodegib—skin cancer	0.00142	0.00895	CcSEcCtD
Fluorescein—Skin disorder—Vismodegib—skin cancer	0.00141	0.00886	CcSEcCtD
Fluorescein—Extravasation—Fluorouracil—skin cancer	0.00136	0.00852	CcSEcCtD
Fluorescein—Respiratory failure—Temozolomide—skin cancer	0.00131	0.00822	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Vismodegib—skin cancer	0.00125	0.00788	CcSEcCtD
Fluorescein—Pain—Vismodegib—skin cancer	0.00124	0.0078	CcSEcCtD
Fluorescein—Gastrointestinal pain—Vismodegib—skin cancer	0.00119	0.00746	CcSEcCtD
Fluorescein—Cardiac disorder—Vemurafenib—skin cancer	0.00117	0.00736	CcSEcCtD
Fluorescein—Neoplasm—Temozolomide—skin cancer	0.00116	0.0073	CcSEcCtD
Fluorescein—Abdominal pain—Vismodegib—skin cancer	0.00115	0.00721	CcSEcCtD
Fluorescein—Angiopathy—Vemurafenib—skin cancer	0.00115	0.0072	CcSEcCtD
Fluorescein—Mediastinal disorder—Vemurafenib—skin cancer	0.00114	0.00715	CcSEcCtD
Fluorescein—Chills—Vemurafenib—skin cancer	0.00113	0.00712	CcSEcCtD
Fluorescein—Cerebrovascular accident—Bleomycin—skin cancer	0.00113	0.00709	CcSEcCtD
Fluorescein—Erythema—Vemurafenib—skin cancer	0.0011	0.0069	CcSEcCtD
Fluorescein—Thrombophlebitis—Temozolomide—skin cancer	0.00108	0.00677	CcSEcCtD
Fluorescein—Dysgeusia—Vemurafenib—skin cancer	0.00108	0.00676	CcSEcCtD
Fluorescein—Asthenia—Vismodegib—skin cancer	0.00104	0.00654	CcSEcCtD
Fluorescein—Pruritus—Vismodegib—skin cancer	0.00103	0.00645	CcSEcCtD
Fluorescein—Nasal congestion—Temozolomide—skin cancer	0.00102	0.00643	CcSEcCtD
Fluorescein—Hot flush—Temozolomide—skin cancer	0.000998	0.00626	CcSEcCtD
Fluorescein—Thrombophlebitis—Fluorouracil—skin cancer	0.000993	0.00624	CcSEcCtD
Fluorescein—Menopausal symptoms—Temozolomide—skin cancer	0.000989	0.00621	CcSEcCtD
Fluorescein—Extravasation—Docetaxel—skin cancer	0.00098	0.00615	CcSEcCtD
Fluorescein—Angiopathy—Imiquimod—skin cancer	0.000977	0.00614	CcSEcCtD
Fluorescein—Immune system disorder—Imiquimod—skin cancer	0.000973	0.00611	CcSEcCtD
Fluorescein—Mediastinal disorder—Imiquimod—skin cancer	0.000971	0.0061	CcSEcCtD
Fluorescein—Chills—Imiquimod—skin cancer	0.000967	0.00607	CcSEcCtD
Fluorescein—Cough—Vemurafenib—skin cancer	0.00096	0.00603	CcSEcCtD
Fluorescein—Bronchospasm—Bleomycin—skin cancer	0.000941	0.00591	CcSEcCtD
Fluorescein—Erythema—Imiquimod—skin cancer	0.000938	0.00589	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.00093	0.00584	CcSEcCtD
Fluorescein—Vomiting—Vismodegib—skin cancer	0.000924	0.0058	CcSEcCtD
Fluorescein—Rash—Vismodegib—skin cancer	0.000916	0.00575	CcSEcCtD
Fluorescein—Dermatitis—Vismodegib—skin cancer	0.000915	0.00575	CcSEcCtD
Fluorescein—Anaphylactic shock—Vemurafenib—skin cancer	0.000897	0.00564	CcSEcCtD
Fluorescein—Nervous system disorder—Vemurafenib—skin cancer	0.00088	0.00553	CcSEcCtD
Fluorescein—Skin disorder—Vemurafenib—skin cancer	0.000872	0.00547	CcSEcCtD
Fluorescein—Respiratory failure—Docetaxel—skin cancer	0.000871	0.00547	CcSEcCtD
Fluorescein—Ill-defined disorder—Imiquimod—skin cancer	0.00087	0.00546	CcSEcCtD
Fluorescein—Nausea—Vismodegib—skin cancer	0.000863	0.00542	CcSEcCtD
Fluorescein—Malaise—Imiquimod—skin cancer	0.000846	0.00531	CcSEcCtD
Fluorescein—Syncope—Imiquimod—skin cancer	0.000841	0.00528	CcSEcCtD
Fluorescein—Hypotension—Vemurafenib—skin cancer	0.000839	0.00527	CcSEcCtD
Fluorescein—Loss of consciousness—Imiquimod—skin cancer	0.000824	0.00518	CcSEcCtD
Fluorescein—Cough—Imiquimod—skin cancer	0.000818	0.00514	CcSEcCtD
Fluorescein—Cardiac arrest—Fluorouracil—skin cancer	0.000818	0.00513	CcSEcCtD
Fluorescein—Convulsion—Imiquimod—skin cancer	0.000813	0.0051	CcSEcCtD
Fluorescein—Hypertension—Imiquimod—skin cancer	0.00081	0.00508	CcSEcCtD
Fluorescein—Chest pain—Imiquimod—skin cancer	0.000798	0.00501	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000793	0.00498	CcSEcCtD
Fluorescein—Discomfort—Imiquimod—skin cancer	0.000789	0.00495	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000775	0.00487	CcSEcCtD
Fluorescein—Neoplasm—Docetaxel—skin cancer	0.000773	0.00485	CcSEcCtD
Fluorescein—Oedema—Imiquimod—skin cancer	0.000765	0.00481	CcSEcCtD
Fluorescein—Hypoaesthesia—Bleomycin—skin cancer	0.000761	0.00478	CcSEcCtD
Fluorescein—Pulmonary oedema—Docetaxel—skin cancer	0.000761	0.00478	CcSEcCtD
Fluorescein—Shock—Imiquimod—skin cancer	0.000753	0.00473	CcSEcCtD
Fluorescein—Nervous system disorder—Imiquimod—skin cancer	0.000751	0.00471	CcSEcCtD
Fluorescein—Tachycardia—Imiquimod—skin cancer	0.000747	0.00469	CcSEcCtD
Fluorescein—Skin disorder—Imiquimod—skin cancer	0.000743	0.00467	CcSEcCtD
Fluorescein—Hyperhidrosis—Imiquimod—skin cancer	0.00074	0.00465	CcSEcCtD
Fluorescein—Angina pectoris—Fluorouracil—skin cancer	0.000724	0.00455	CcSEcCtD
Fluorescein—Thrombophlebitis—Docetaxel—skin cancer	0.000717	0.0045	CcSEcCtD
Fluorescein—Paraesthesia—Imiquimod—skin cancer	0.000687	0.00432	CcSEcCtD
Fluorescein—Chills—Bleomycin—skin cancer	0.000687	0.00431	CcSEcCtD
Fluorescein—Dyspnoea—Imiquimod—skin cancer	0.000682	0.00428	CcSEcCtD
Fluorescein—Erythema—Bleomycin—skin cancer	0.000666	0.00418	CcSEcCtD
Fluorescein—Hot flush—Docetaxel—skin cancer	0.000663	0.00417	CcSEcCtD
Fluorescein—Hypersensitivity—Vemurafenib—skin cancer	0.000661	0.00415	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Imiquimod—skin cancer	0.000661	0.00415	CcSEcCtD
Fluorescein—Menopausal symptoms—Docetaxel—skin cancer	0.000658	0.00413	CcSEcCtD
Fluorescein—Pain—Imiquimod—skin cancer	0.000654	0.00411	CcSEcCtD
Fluorescein—Asthenia—Vemurafenib—skin cancer	0.000644	0.00404	CcSEcCtD
Fluorescein—Hypoaesthesia—Temozolomide—skin cancer	0.000642	0.00403	CcSEcCtD
Fluorescein—Chills—Dactinomycin—skin cancer	0.00064	0.00402	CcSEcCtD
Fluorescein—Pruritus—Vemurafenib—skin cancer	0.000635	0.00399	CcSEcCtD
Fluorescein—Feeling abnormal—Imiquimod—skin cancer	0.000631	0.00396	CcSEcCtD
Fluorescein—Gastrointestinal pain—Imiquimod—skin cancer	0.000626	0.00393	CcSEcCtD
Fluorescein—Erythema—Dactinomycin—skin cancer	0.000621	0.0039	CcSEcCtD
Fluorescein—Ill-defined disorder—Bleomycin—skin cancer	0.000618	0.00388	CcSEcCtD
Fluorescein—Urticaria—Imiquimod—skin cancer	0.000608	0.00382	CcSEcCtD
Fluorescein—Abdominal pain—Imiquimod—skin cancer	0.000605	0.0038	CcSEcCtD
Fluorescein—Malaise—Bleomycin—skin cancer	0.000601	0.00377	CcSEcCtD
Fluorescein—Cardiac disorder—Temozolomide—skin cancer	0.000599	0.00376	CcSEcCtD
Fluorescein—Dizziness—Vemurafenib—skin cancer	0.000593	0.00373	CcSEcCtD
Fluorescein—Hypoaesthesia—Fluorouracil—skin cancer	0.000592	0.00372	CcSEcCtD
Fluorescein—Angiopathy—Temozolomide—skin cancer	0.000586	0.00368	CcSEcCtD
Fluorescein—Immune system disorder—Temozolomide—skin cancer	0.000583	0.00366	CcSEcCtD
Fluorescein—Mediastinal disorder—Temozolomide—skin cancer	0.000582	0.00365	CcSEcCtD
Fluorescein—Cough—Bleomycin—skin cancer	0.000581	0.00365	CcSEcCtD
Fluorescein—Chills—Temozolomide—skin cancer	0.000579	0.00364	CcSEcCtD
Fluorescein—Ill-defined disorder—Dactinomycin—skin cancer	0.000577	0.00362	CcSEcCtD
Fluorescein—Vomiting—Vemurafenib—skin cancer	0.000571	0.00358	CcSEcCtD
Fluorescein—Chest pain—Bleomycin—skin cancer	0.000567	0.00356	CcSEcCtD
Fluorescein—Rash—Vemurafenib—skin cancer	0.000566	0.00355	CcSEcCtD
Fluorescein—Dermatitis—Vemurafenib—skin cancer	0.000565	0.00355	CcSEcCtD
Fluorescein—Hypersensitivity—Imiquimod—skin cancer	0.000564	0.00354	CcSEcCtD
Fluorescein—Headache—Vemurafenib—skin cancer	0.000562	0.00353	CcSEcCtD
Fluorescein—Erythema—Temozolomide—skin cancer	0.000562	0.00353	CcSEcCtD
Fluorescein—Discomfort—Bleomycin—skin cancer	0.00056	0.00352	CcSEcCtD
Fluorescein—Malaise—Dactinomycin—skin cancer	0.00056	0.00352	CcSEcCtD
Fluorescein—Dysgeusia—Temozolomide—skin cancer	0.00055	0.00346	CcSEcCtD
Fluorescein—Asthenia—Imiquimod—skin cancer	0.000549	0.00345	CcSEcCtD
Fluorescein—Anaphylactic shock—Bleomycin—skin cancer	0.000544	0.00341	CcSEcCtD
Fluorescein—Oedema—Bleomycin—skin cancer	0.000544	0.00341	CcSEcCtD
Fluorescein—Pruritus—Imiquimod—skin cancer	0.000541	0.0034	CcSEcCtD
Fluorescein—Nausea—Vemurafenib—skin cancer	0.000533	0.00335	CcSEcCtD
Fluorescein—Bronchospasm—Docetaxel—skin cancer	0.000528	0.00331	CcSEcCtD
Fluorescein—Tremor—Temozolomide—skin cancer	0.000527	0.00331	CcSEcCtD
Fluorescein—Discomfort—Dactinomycin—skin cancer	0.000523	0.00328	CcSEcCtD
Fluorescein—Angina pectoris—Docetaxel—skin cancer	0.000522	0.00328	CcSEcCtD
Fluorescein—Ill-defined disorder—Temozolomide—skin cancer	0.000521	0.00327	CcSEcCtD
Fluorescein—Erythema—Fluorouracil—skin cancer	0.000518	0.00325	CcSEcCtD
Fluorescein—Hypotension—Bleomycin—skin cancer	0.000508	0.00319	CcSEcCtD
Fluorescein—Oedema—Dactinomycin—skin cancer	0.000507	0.00318	CcSEcCtD
Fluorescein—Malaise—Temozolomide—skin cancer	0.000507	0.00318	CcSEcCtD
Fluorescein—Dizziness—Imiquimod—skin cancer	0.000506	0.00318	CcSEcCtD
Fluorescein—Cough—Temozolomide—skin cancer	0.00049	0.00308	CcSEcCtD
Fluorescein—Paraesthesia—Bleomycin—skin cancer	0.000488	0.00307	CcSEcCtD
Fluorescein—Convulsion—Temozolomide—skin cancer	0.000487	0.00306	CcSEcCtD
Fluorescein—Vomiting—Imiquimod—skin cancer	0.000487	0.00306	CcSEcCtD
Fluorescein—Hypertension—Temozolomide—skin cancer	0.000485	0.00305	CcSEcCtD
Fluorescein—Dyspnoea—Bleomycin—skin cancer	0.000485	0.00304	CcSEcCtD
Fluorescein—Rash—Imiquimod—skin cancer	0.000483	0.00303	CcSEcCtD
Fluorescein—Dermatitis—Imiquimod—skin cancer	0.000482	0.00303	CcSEcCtD
Fluorescein—Headache—Imiquimod—skin cancer	0.000479	0.00301	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000475	0.00298	CcSEcCtD
Fluorescein—Discomfort—Temozolomide—skin cancer	0.000473	0.00297	CcSEcCtD
Fluorescein—Pain—Bleomycin—skin cancer	0.000465	0.00292	CcSEcCtD
Fluorescein—Anaphylactic shock—Temozolomide—skin cancer	0.000459	0.00288	CcSEcCtD
Fluorescein—Oedema—Temozolomide—skin cancer	0.000459	0.00288	CcSEcCtD
Fluorescein—Nausea—Imiquimod—skin cancer	0.000455	0.00285	CcSEcCtD
Fluorescein—Nervous system disorder—Temozolomide—skin cancer	0.00045	0.00282	CcSEcCtD
Fluorescein—Convulsion—Fluorouracil—skin cancer	0.000449	0.00282	CcSEcCtD
Fluorescein—Feeling abnormal—Bleomycin—skin cancer	0.000448	0.00281	CcSEcCtD
Fluorescein—Skin disorder—Temozolomide—skin cancer	0.000446	0.0028	CcSEcCtD
Fluorescein—Hyperhidrosis—Temozolomide—skin cancer	0.000443	0.00278	CcSEcCtD
Fluorescein—Chest pain—Fluorouracil—skin cancer	0.000441	0.00277	CcSEcCtD
Fluorescein—Discomfort—Fluorouracil—skin cancer	0.000436	0.00273	CcSEcCtD
Fluorescein—Pain—Dactinomycin—skin cancer	0.000434	0.00272	CcSEcCtD
Fluorescein—Urticaria—Bleomycin—skin cancer	0.000432	0.00271	CcSEcCtD
Fluorescein—Hypoaesthesia—Docetaxel—skin cancer	0.000427	0.00268	CcSEcCtD
Fluorescein—Anaphylactic shock—Fluorouracil—skin cancer	0.000423	0.00265	CcSEcCtD
Fluorescein—Oedema—Fluorouracil—skin cancer	0.000423	0.00265	CcSEcCtD
Fluorescein—Feeling abnormal—Dactinomycin—skin cancer	0.000418	0.00262	CcSEcCtD
Fluorescein—Gastrointestinal pain—Dactinomycin—skin cancer	0.000415	0.0026	CcSEcCtD
Fluorescein—Nervous system disorder—Fluorouracil—skin cancer	0.000414	0.0026	CcSEcCtD
Fluorescein—Tachycardia—Fluorouracil—skin cancer	0.000412	0.00259	CcSEcCtD
Fluorescein—Paraesthesia—Temozolomide—skin cancer	0.000412	0.00259	CcSEcCtD
Fluorescein—Dyspnoea—Temozolomide—skin cancer	0.000409	0.00257	CcSEcCtD
Fluorescein—Abdominal pain—Dactinomycin—skin cancer	0.000401	0.00252	CcSEcCtD
Fluorescein—Hypersensitivity—Bleomycin—skin cancer	0.000401	0.00252	CcSEcCtD
Fluorescein—Cardiac disorder—Docetaxel—skin cancer	0.000398	0.0025	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Temozolomide—skin cancer	0.000396	0.00249	CcSEcCtD
Fluorescein—Hypotension—Fluorouracil—skin cancer	0.000395	0.00248	CcSEcCtD
Fluorescein—Pain—Temozolomide—skin cancer	0.000392	0.00246	CcSEcCtD
Fluorescein—Asthenia—Bleomycin—skin cancer	0.00039	0.00245	CcSEcCtD
Fluorescein—Angiopathy—Docetaxel—skin cancer	0.00039	0.00245	CcSEcCtD
Fluorescein—Immune system disorder—Docetaxel—skin cancer	0.000388	0.00243	CcSEcCtD
Fluorescein—Mediastinal disorder—Docetaxel—skin cancer	0.000387	0.00243	CcSEcCtD
Fluorescein—Chills—Docetaxel—skin cancer	0.000385	0.00242	CcSEcCtD
Fluorescein—Pruritus—Bleomycin—skin cancer	0.000385	0.00242	CcSEcCtD
Fluorescein—Paraesthesia—Fluorouracil—skin cancer	0.000379	0.00238	CcSEcCtD
Fluorescein—Feeling abnormal—Temozolomide—skin cancer	0.000378	0.00237	CcSEcCtD
Fluorescein—Dyspnoea—Fluorouracil—skin cancer	0.000377	0.00237	CcSEcCtD
Fluorescein—Gastrointestinal pain—Temozolomide—skin cancer	0.000375	0.00236	CcSEcCtD
Fluorescein—Erythema—Docetaxel—skin cancer	0.000374	0.00235	CcSEcCtD
Fluorescein—Hypersensitivity—Dactinomycin—skin cancer	0.000374	0.00235	CcSEcCtD
Fluorescein—Dysgeusia—Docetaxel—skin cancer	0.000366	0.0023	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000365	0.00229	CcSEcCtD
Fluorescein—Urticaria—Temozolomide—skin cancer	0.000364	0.00229	CcSEcCtD
Fluorescein—Asthenia—Dactinomycin—skin cancer	0.000364	0.00228	CcSEcCtD
Fluorescein—Abdominal pain—Temozolomide—skin cancer	0.000363	0.00228	CcSEcCtD
Fluorescein—Pain—Fluorouracil—skin cancer	0.000361	0.00227	CcSEcCtD
Fluorescein—Feeling abnormal—Fluorouracil—skin cancer	0.000348	0.00219	CcSEcCtD
Fluorescein—Vomiting—Bleomycin—skin cancer	0.000346	0.00217	CcSEcCtD
Fluorescein—Rash—Bleomycin—skin cancer	0.000343	0.00215	CcSEcCtD
Fluorescein—Dermatitis—Bleomycin—skin cancer	0.000343	0.00215	CcSEcCtD
Fluorescein—Hypersensitivity—Temozolomide—skin cancer	0.000338	0.00212	CcSEcCtD
Fluorescein—Urticaria—Fluorouracil—skin cancer	0.000336	0.00211	CcSEcCtD
Fluorescein—Syncope—Docetaxel—skin cancer	0.000335	0.0021	CcSEcCtD
Fluorescein—Asthenia—Temozolomide—skin cancer	0.000329	0.00207	CcSEcCtD
Fluorescein—Loss of consciousness—Docetaxel—skin cancer	0.000328	0.00206	CcSEcCtD
Fluorescein—Cough—Docetaxel—skin cancer	0.000326	0.00205	CcSEcCtD
Fluorescein—Pruritus—Temozolomide—skin cancer	0.000324	0.00204	CcSEcCtD
Fluorescein—Convulsion—Docetaxel—skin cancer	0.000324	0.00203	CcSEcCtD
Fluorescein—Nausea—Bleomycin—skin cancer	0.000323	0.00203	CcSEcCtD
Fluorescein—Hypertension—Docetaxel—skin cancer	0.000323	0.00203	CcSEcCtD
Fluorescein—Vomiting—Dactinomycin—skin cancer	0.000322	0.00202	CcSEcCtD
Fluorescein—Rash—Dactinomycin—skin cancer	0.00032	0.00201	CcSEcCtD
Fluorescein—Chest pain—Docetaxel—skin cancer	0.000318	0.002	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000316	0.00198	CcSEcCtD
Fluorescein—Hypersensitivity—Fluorouracil—skin cancer	0.000311	0.00196	CcSEcCtD
Fluorescein—Anaphylactic shock—Docetaxel—skin cancer	0.000305	0.00192	CcSEcCtD
Fluorescein—Oedema—Docetaxel—skin cancer	0.000305	0.00192	CcSEcCtD
Fluorescein—Dizziness—Temozolomide—skin cancer	0.000303	0.0019	CcSEcCtD
Fluorescein—Nausea—Dactinomycin—skin cancer	0.000301	0.00189	CcSEcCtD
Fluorescein—Shock—Docetaxel—skin cancer	0.0003	0.00188	CcSEcCtD
Fluorescein—Nervous system disorder—Docetaxel—skin cancer	0.000299	0.00188	CcSEcCtD
Fluorescein—Pruritus—Fluorouracil—skin cancer	0.000299	0.00188	CcSEcCtD
Fluorescein—Tachycardia—Docetaxel—skin cancer	0.000298	0.00187	CcSEcCtD
Fluorescein—Skin disorder—Docetaxel—skin cancer	0.000296	0.00186	CcSEcCtD
Fluorescein—Vomiting—Temozolomide—skin cancer	0.000292	0.00183	CcSEcCtD
Fluorescein—Rash—Temozolomide—skin cancer	0.000289	0.00182	CcSEcCtD
Fluorescein—Dermatitis—Temozolomide—skin cancer	0.000289	0.00181	CcSEcCtD
Fluorescein—Headache—Temozolomide—skin cancer	0.000287	0.0018	CcSEcCtD
Fluorescein—Hypotension—Docetaxel—skin cancer	0.000285	0.00179	CcSEcCtD
Fluorescein—Dizziness—Fluorouracil—skin cancer	0.000279	0.00175	CcSEcCtD
Fluorescein—Paraesthesia—Docetaxel—skin cancer	0.000274	0.00172	CcSEcCtD
Fluorescein—Nausea—Temozolomide—skin cancer	0.000272	0.00171	CcSEcCtD
Fluorescein—Dyspnoea—Docetaxel—skin cancer	0.000272	0.00171	CcSEcCtD
Fluorescein—Vomiting—Fluorouracil—skin cancer	0.000269	0.00169	CcSEcCtD
Fluorescein—Rash—Fluorouracil—skin cancer	0.000266	0.00167	CcSEcCtD
Fluorescein—Dermatitis—Fluorouracil—skin cancer	0.000266	0.00167	CcSEcCtD
Fluorescein—Headache—Fluorouracil—skin cancer	0.000265	0.00166	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Docetaxel—skin cancer	0.000263	0.00165	CcSEcCtD
Fluorescein—Pain—Docetaxel—skin cancer	0.000261	0.00164	CcSEcCtD
Fluorescein—Feeling abnormal—Docetaxel—skin cancer	0.000251	0.00158	CcSEcCtD
Fluorescein—Nausea—Fluorouracil—skin cancer	0.000251	0.00158	CcSEcCtD
Fluorescein—Gastrointestinal pain—Docetaxel—skin cancer	0.000249	0.00157	CcSEcCtD
Fluorescein—Abdominal pain—Docetaxel—skin cancer	0.000241	0.00151	CcSEcCtD
Fluorescein—Hypersensitivity—Docetaxel—skin cancer	0.000225	0.00141	CcSEcCtD
Fluorescein—Asthenia—Docetaxel—skin cancer	0.000219	0.00137	CcSEcCtD
Fluorescein—Pruritus—Docetaxel—skin cancer	0.000216	0.00136	CcSEcCtD
Fluorescein—Dizziness—Docetaxel—skin cancer	0.000202	0.00127	CcSEcCtD
Fluorescein—Vomiting—Docetaxel—skin cancer	0.000194	0.00122	CcSEcCtD
Fluorescein—Rash—Docetaxel—skin cancer	0.000192	0.00121	CcSEcCtD
Fluorescein—Dermatitis—Docetaxel—skin cancer	0.000192	0.00121	CcSEcCtD
Fluorescein—Headache—Docetaxel—skin cancer	0.000191	0.0012	CcSEcCtD
Fluorescein—Nausea—Docetaxel—skin cancer	0.000181	0.00114	CcSEcCtD
